This topic contains a solution. Click here to go to the answer

Author Question: According to political scientist Peter Evans, who benefits the most from collective action? a. ... (Read 62 times)

RODY.ELKHALIL

  • Hero Member
  • *****
  • Posts: 591
According to political scientist Peter Evans, who benefits
 
  the most from collective action?
  a. politically-connected elites
  b. less-privileged people
  c. paid interest group staff
  d. wealthy individuals

Question 2

Early voting studies found that:
 
  a. persons with high education were more likely to vote than those with low levels.
  b. those with higher income were less likely to vote than those with lower income.
  c. in the United States, there was no correlation between income level and voting turnout.
  d. party affiliation and education level determine who votes.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

flannelavenger

  • Sr. Member
  • ****
  • Posts: 322
Answer to Question 1

Answer: b

Answer to Question 2

Answer: a




RODY.ELKHALIL

  • Member
  • Posts: 591
Reply 2 on: Jul 8, 2018
YES! Correct, THANKS for helping me on my review


cassie_ragen

  • Member
  • Posts: 347
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

More than one-third of adult Americans are obese. Diseases that kill the largest number of people annually, such as heart disease, cancer, diabetes, stroke, and hypertension, can be attributed to diet.

Did you know?

It is believed that humans initially contracted crabs from gorillas about 3 million years ago from either sleeping in gorilla nests or eating the apes.

Did you know?

Your heart beats over 36 million times a year.

Did you know?

If all the neurons in the human body were lined up, they would stretch more than 600 miles.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library